Introduction
============

Plasticity of organogenesis provides an opportunity for interventions in a specific window of early development that may have long-term beneficial or detrimental effects on adult health and disease (McMillen and Robinson, [@B18]). One critical regulation of such plasticity is protein synthesis. Upstream factors affecting protein synthesis include tight regulations at multiple stages of ribosome biogenesis. For example, it is well known that epigenetic silencing of ribosomal DNA (rDNA) regularly occurs, even in proliferating cells (McStay and Grummt, [@B19]; Sanij and Hannan, [@B22]). One exogenous factor that has been shown to affect rDNA and ribosome biogenesis is nitric oxide (NO). Exposure of cells to high levels of NO, using either NO-donors, or inducing expression of inducible NO synthase (iNOS), results in inhibition of the 80S ribosomal complex (Kim et al., [@B13]) and enhanced rRNA cleavage resulting in a reduction of both 60S and 80S ribosomal particles (Cai et al., [@B5]).

Hypertension is associated with decreased NO availability (Wilcox, [@B28]). The fawn-hooded hypertensive rat (FHH) is a genetic model of hypertension susceptible to progressive renal injury. In FHH hypertension is aggravated and the development of renal injury is accelerated when NOS is chronically inhibited, revealing partial NO dependency of the adult FHH phenotype (Van Dokkum et al., [@B26]). Renal transplantation under different conditions has shown that blood pressure regulation is intricately linked to the kidney (Smallegange et al., [@B24]; Crowley et al., [@B9]), and we hypothesized that this is also the case in the perinatal phase (Koeners et al., [@B14]). Recently, we observed that perinatal supplementation of FHH dams with molsidomine, an NO-releasing prodrug (Feelisch, [@B10]; Singh et al., [@B23]), persistently lowered the blood pressure and attenuated the development of renal injury in male and female FHH (Koeners et al., [@B15]).

Long-term regulation of blood pressure is determined by the relationship between renal perfusion pressure and NaCl excretion, and this relationship is facilitated by renal NO availability (Cowley, [@B8]; Garvin et al., [@B11]). Thus our interest is directed at mechanisms in the kidney that link availability of NO in early development to regulation blood pressure in adult life. Conceivably temporal changes in the regulation of renal protein synthesis via ribosomal control of gene translation could constitute such a link (Kasinath et al., [@B12]). For instance, compensatory renal hypertrophy involves a global increase in polysome profiles within less than 1 day after uninephrectomy (Chen et al., [@B7]). Based on the known effects of high levels of NO on the ribosomal elements in cultured cells, we hypothesized that ribosome biogenesis *in vivo* in the neonatal FHH kidney may also be regulated by NO availability. This perinatal regulation of ribosome biogenesis may then affect kidney organogenesis in a manner that impacts the long-term regulation of blood pressure and renal integrity.

Here we demonstrate that the perinatal administration of NO results in a dramatic biphasic change of ribosomal protein gene expression in FHH rats at 2 days and 2 weeks of age. This results in decreased post-translational levels of certain ribosomal proteins, and a remarkable reduction of assembled ribosome structures at the 2-week point. Intriguingly, we did not find an increase in renal NO content at 2 weeks in the offspring of NO-donor-treated rats. Our results suggest that the increased availability of NO in gestation epigenetically alters renal ribosome biogenesis during a critical period of renal development. In conjunction with previously published findings, we conclude that this effect by NO may alter renal organogenesis in a manner that alleviates the hypertension phenotype normally experienced by FHH rats.

Materials and Methods
=====================

Animal experiment
-----------------

Fawn-hooded hypertensive rat were from our own colony, derived from the original colony at Erasmus University Rotterdam (FHH/EUR) maintained by Dr. A. Provoost. FHH dams were supplied with molsidomine (Sigma-Aldrich, Zwijndrecht, Netherlands) in drinking water (120 mg/L) 2 weeks before to 4 weeks after birth. Control FHH mothers and their offspring received regular tap water. All offspring from 4 weeks of age received regular tap water and regular chow (Special Diets Services, Witham, Essex, England). Offspring were sacrificed at 2 days, 2 weeks, 36 weeks (males), and 42 weeks (females). The adult ages were chosen when renal injury in males and females was similar. Kidneys were isolated and snap-frozen (for microarray analysis), kept on ice (for Western blotting and polysome profiling), or fixed in formaldehyde (for immunohistochemistry). Note that although functional and morphological data from the adult rats have been published previously (Koeners et al., [@B15]), all microarray data and all data pertaining to renal ribosomal proteins in adult kidneys is novel. Directly after weaning of the pups, the dams were placed in metabolic cages without food but with access to water with 2% glucose and 24-h urine was collected on antibiotic/antimycotic solution (Sigma-Aldrich) to prevent degradation of NO metabolites. NO metabolites were determined as described (Bongartz et al., [@B3]). Sentinel animals were housed under the same conditions and regularly monitored for infections by nematodes, pathogenic bacteria, and antibodies for rodent viral pathogens (International Council for Laboratory Animal Science, Nijmegen, Netherlands). The Utrecht University Board for studies in experimental animals approved the protocol.

Microarray
----------

For an overview and extensive explanation of microarray data processing, please see [Appendix](#A1){ref-type="app"}. In short, a piece of snap-frozen kidney was put in 1 mL TRIzol (Invitrogen, Breda, Netherlands) containing 100--150 mg 1 mm glass beads (BioSpec Products, Bartlesville, OK, USA) and immediately homogenized in 30 s using a mini-beadbeater (BioSpec). The total RNA was isolated according to the manufacturer's instructions. Total RNA was purified using NucleoSpin RNA II kit (Macherey-Nagel, Düren, Germany). Samples were then put on Illumina BeadChips (RatRef-12) by ServiceXS[^1^](#fn1){ref-type="fn"} (Leiden, Netherlands). Kidneys from 2 days, 2 weeks, and adult FHH of both genders were used (at least *n* = 5/group). All samples were randomly placed on different arrays in order to minimize variation between BeadChips and between arrays.

After calculating the average intensity per probe, all arrays were Log~2~-transformed and Quantile normalized. The arrays were grouped and the average intensity was calculated. The significance of the differences in intensity between the groups was calculated using Cyber *t*-test. This final data containing normalized data, average intensity per group and statistical significance between groups were used in data evaluation. The data are submitted as MIAME-complaint to GEO[^2^](#fn2){ref-type="fn"} under accession number GSE27725.

The number of genes differentially expressed in the molsidomine samples were counted per age in each gender. These were then compared in order to elucidate whether there were genes persistently affected by molsidomine. The 40 genes that were most differentially regulated (20 up and 20 down) by molsidomine were collected at each age for each gender.

All genes encoding for ribosomal proteins were collected. The differentially expressed genes encoding for ribosomal proteins were compared at each age. In order to determine whether the effect of molsidomine on ribosomal genes was stronger than on general gene expression profiles, the ratio of differentially regulated ribosomal genes to the whole ribosomal gene population was compared to the ratio of total differentially expressed genes with whole microarray data in a size test.

Western blot analysis
---------------------

Fresh kidney samples were lysed on ice in lysis buffer (50 mM Tris--HCl pH 7.5, 150 mM NaCl, 2 mM EDTA, 1% Triton X-100; all from Sigma-Aldrich) plus protease inhibitors (Santa Cruz Biotech, \#29130) and subjected to centrifugation at 14K rpm at 4°C for 10 min. Protein content in the supernatants was quantified using Biorad Protein Assay. 6× Laemmli loading buffer was added to 50 μg samples which were then boiled for 5 min and loaded on a 10% SDS/PAGE gel. Transfers to PVDF membranes (Millipore, \#IPVH00010) were done overnight at 15 V at 4°C, blocked in 5% milk/TBST solution for 1 h at RT, and subjected to blotting with αL36a (Abnova, \#H00006173-M02) or α-actin (Santa Cruz Biotech, \#1616) at dilutions of 1:200 in blocking buffer overnight at 4°C. Either α-mouse (L36a) or α-rabbit (actin) HRP-conjugated secondary antibodies (GE Healthcare, \#NXA931 and NA934) were used at a dilution of 1:5000 in TBST for 20 min at RT. Blots were washed 3× in TBST for 10 min at RT. Detection was done with the ECL Advance Western Blot Detection Kit (GE Healthcare, \#RPN2135). Quantifications were performed using a GS-800 densitometer (Biorad, Veenendaal, Netherlands) and Quantity One software (Biorad).

Polysome profiling
------------------

The kidneys from FHH pups from control dams or dams treated with molsidomine were collected at age 2 days and 2 weeks, maintained fresh on ice, and processed for polysome profiling on the same day. For polysome profiling of adult tissue frozen kidney tissue was used. Comparisons were only performed between treated and control rats of both genders at each age. Livers from 2-week-old pups were used to determine tissue-specificity.

All steps of this protocol were performed at 4°C or on ice. Gradients of 17--50% sucrose (11 ml) in gradient buffer (110 mM KAc, 20 mM MgAc~2~, and 10 mM HEPES pH 7.6) were prepared on the day prior to use. Kidneys were lysed in 500 μl polysome lysis buffer (gradient buffer containing 100 mM KCl, 10 mM MgCl~2~, 0.1% NP-40, 2 mM DTT, and 40 U/ml RNasin; Promega, Leiden, Netherlands) using a dounce homogenizer. The samples were centrifuged at 1200 g for 10 min to remove debris and loaded onto sucrose gradients. The gradients were ultracentrifuged for 2 h at 40,000 rpm in an SW41Ti rotor (Beckman-Coulter, USA). The gradients were displaced into a UA6 absorbance reader (Teledyne ISCO, USA) using a syringe pump (Brandel, USA) containing 60% sucrose. Absorbance was recorded at an OD of 254 nm. All chemicals came from Sigma-Aldrich unless stated otherwise.

Tissue NO content
-----------------

Endogenous NO levels in kidney and liver tissues of FHH pups were assayed at 2 weeks by NO trapping with iron-dithiocarbamate (Fe-DETC) complexes, as previously described (Koeners et al., [@B16]; Van Faassen et al., [@B27]). Briefly, the yields of paramagnetic NO-Fe(II)-DETC complexes (mononitrosyl-iron complexes, MNIC) in tissues was quantified with EPR spectroscopy of intact frozen tissue sections at 77K. The tissues were reduced at room temperature with dithionite (50 mM for 15 min) to remove the overlapping EPR signal from paramagnetic Cu(II)-DETC complexes as commonly found in biological materials.

Immunohistochemistry
--------------------

Kidneys were fixed overnight at room temperature in 4% formaldehyde. The tissue was embedded in paraffin and 4 μm sections were made on silanized glass slides. The slides were baked at 58°C overnight, deparaffinated, and rehydrated. Endogenous peroxidase was blocked using citric acid. For antigen retrieval, the sections were boiled for 20 min in citrate buffer (pH 6) and allowed to cool slowly. The sections were then blocked in 1% BSA (w/v) in PBS and incubated with rabbit-anti-pH3 (Santa Cruz Biotech, \#1791) overnight at 4°C. The sections were then incubated in anti-rabbit Powervision PO (Immunologic, \#DPVR110 HRP) for 30 min at RT and developed using DAB. Finally the sections were counterstained in hematoxylin, dehydrated, and enclosed in pertex. The quantification was performed as follows: At 20× magnification random fields were chosen, taking care not to include the edges of the tissue. The number of positive cells was counted in three fields of two sections per kidney. The average of these six counts was used for analysis.

Statistics
----------

For statistics in microarray, please refer to the methodology. For other measurements the values are expressed as means ± SEM. Data were compared with unpaired *t*-test, one-way ANOVA, and two-way ANOVA where appropriate followed by *post hoc* test Student-Newman--Keuls. *P* \< 0.05 is considered significant.

Results
=======

Biometrical data
----------------

Biometrical data of FHH offspring and the number of rats studied are collected in Table [1](#T1){ref-type="table"}. Note that adult kidney weight and tail-cuff blood pressure data, which were published previously (Koeners et al., [@B15]), are included in the table for the sake of convenience. Molsidomine treatment decreased the kidney weight relative to body weight in 2-day-old females (*P* \< 0.05) but not at older ages. However, in both male and female 2-week-old FHH rats relative kidney weight was unchanged. The kidneys of adult males exposed to perinatal molsidomine weighed less than controls, probably in association with reduced injury (Koeners et al., [@B15]). Perinatal molsidomine decreased systolic blood pressure in adult FHH offspring (Koeners et al., [@B15]). NO metabolites were determined in a 24-h collection of urine from FHH dams to substantiate the direct effects of molsidomine in their pups. Indeed, maternal urine NOx was increased by molsidomine (*n* = 4) vs. controls (*n* = 4) from 1.6 ± 0.1 to 2.6 ± 0.2 μmol/(100 g BW)/d (*P* \< 0.01).

###### 

**Biometrical data of control FHH and FHH during molsidomine (2 days and 2 weeks) or after perinatal molsidomine (adult)**.

                                     Males       Females                                                    
  ---------------------------------- ----------- ---------------------------------------------- ----------- ---------------------------------------------
  **2 DAYS**                                                                                                
  Number of pups/number of litters   12/7        12/7                                           12/6        19/10
  RKW/BW (mg/g)                      4.9 ± 0.1   4.8 ± 0.1                                      5.3 ± 0.1   4.9 ± 0.1[^\#^](#tfn1){ref-type="table-fn"}
  **2 WEEKS**                                                                                               
  Number/litters                     15/8        17/10                                          13/8        18/10
  RKW/BW (mg/g)                      5.2 ± 0.1   5.3 ± 0.1                                      5.3 ± 0.1   5.5 ± 0.1
  **ADULT**                                                                                                 
  Number/litters                     23/10       13/4                                           24/10       16/5
  RKW/BW (mg/g)                      3.8 ± 0.1   3.4 ± 0.03[^\#^](#tfn1){ref-type="table-fn"}   4.4 ± 0.1   4.3 ± 0.1
  Systolic blood pressure (mmHg)     158 ± 3     139 ± 4[^\#^](#tfn1){ref-type="table-fn"}      145 ± 5     118 ± 5[^\#^](#tfn1){ref-type="table-fn"}

*^\#^P \< 0.05 vs. controls of same gender. Biometrical data in adults published previously (Koeners et al., [@B15]) are included for the sake of convenience*.

Tissue NO content
-----------------

Although the NO-donor increased maternal NO metabolite excretion, the NO status of 2-week-old renal (and liver) tissue was unchanged as assayed by EPR spectroscopy of NO trapped with iron-dithiocarbamate complexes (Table [2](#T2){ref-type="table"}). Unfortunately, the NO trapping procedure is not possible in 2-day-old pups.

###### 

**Nitric oxide yields (pmol MNIC/mg tissue) determined by EPR in kidneys and liver in of 2-week-old control FHH and 2-week-old FHH offspring of dams treated with molsidomine**.

                                        Males         Females                     
  ------------------------------------- ------------- ------------- ------------- -------------
  **2 WEEKS**                                                                     
  Number/litters                        4/2           7/4           4/2           8/4
  NO yield in kidney (left and right)   0.49 ± 0.03   0.53 ± 0.01   0.50 ± 0.04   0.49 ± 0.02
  NO yield in liver                     1.30 ± 0.08   1.39 ± 0.04   1.35 ± 0.08   1.32 ± 0.04

*MNIC, mononitrosyl-iron complexes*.

Microarray
----------

Perinatal treatment with molsidomine significantly affected transcription of hundreds of genes at 2 days and at older ages (see Figure [A1](#FA1){ref-type="fig"} in Appendix). The data also clearly shows that the transcriptional effect of molsidomine differs between ages. Few genes remained differentially expressed at all ages and those that did displayed bidirectional expression between ages.

The 40 most differentially expressed genes (20 induced and 20 reduced) were nearly all different between males and females at the same age. Several genes encoding for ribosomal proteins were present in the top 20 genes in males at all ages, however were less present in the top 20 of females (see Tables [A1](#TA1){ref-type="table"} in Appendix).

The present study is focused on the changes in ribosomal protein gene expression. Remarkably, these ribosomal protein genes in males were differentially induced by molsidomine at 2 days, then differentially reduced by molsidomine at both 2 weeks and in adults (see Figures [1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}; the collection of genes are shown in Table [A2](#TA2){ref-type="table"} in Appendix). These changes in ribosomal protein gene expression were significant at all ages (*P* \< 0.05) and this effect was specific for ribosomal genes only in males (vs. all genes in the microarray; *P* \< 0.001).

![**Number of ribosomal protein genes that are differentially expressed by molsidomine at each age per gender**. The distribution of these genes between ages per gender is shown in the Venn diagram. Below the diagram is noted the total number of ribosomal protein genes that are significantly differentially expressed in molsidomine vs. control FHH rats at each age.](fgene-02-00052-g001){#F1}

![**Ribosomal protein genes in kidneys of FHH males differentially expressed by molsidomine at 2 weeks and whether these genes were also regulated at other ages**. All genes that are significantly differentially expressed by molsidomine at 2 weeks are ranked (middle panel). Some of these genes were also regulated at 2 days (upper panel) and in adults (lower panel). The ratio of the genes is expressed as Log2(FM/FC), where FM and FC are the normalized intensities of gene expression in the molsidomine and control groups, respectively. Significant differential expression is indicated by a closed bar, non-significant differential expression by an open bar.](fgene-02-00052-g002){#F2}

Protein expression of L36a
--------------------------

In order to determine if the changes in ribosomal protein gene expression suggested by the microarray analysis could be verified at the protein level, we analyzed the expression of ribosomal protein L36a at 2 days and 2 weeks. Table [A2](#TA2){ref-type="table"} in Appendix shows that genes coding for the ribosomal protein L36a are subject to some of the most significant up-regulation at 2 days and down-regulation at 2 weeks (and in adults) in molsidomine-treated FHH males. Note that more than one ribosomal protein L36a gene from different chromosomes is listed on Table [2](#T2){ref-type="table"}. Western blot analysis of kidney samples of FHH rats demonstrated that ribosomal protein L36a protein tends to be down-regulated by molsidomine in 2 week males (Figure [3](#F3){ref-type="fig"}). Quantification of three independent experiments verified that this change in ribosomal protein L36a protein expression occurred only in molsidomine-treated males at 2 weeks (Figure [3](#F3){ref-type="fig"}). These results suggest that despite the increase in ribosomal protein gene expression seen in 2-day-old molsidomine-treated FHH males, this increases does not manifest as an increase in ribosomal protein levels (see also Figure [4](#F4){ref-type="fig"}). In contrast, the western blot results suggest that the decrease in ribosomal protein gene expression at 2 weeks in molsidomine-treated rats indeed does affect L36a proteins levels, as also supported by the profiles of Figure [4](#F4){ref-type="fig"}.

![**Western Blot on ribosomal protein L36a**. Western blot analysis was performed on kidneys lysates from 2 day and 2 week control and molsidomine FHH rats of both genders using an antibody against ribosomal protein L36a (upper panel). The measured band intensity of ribosomal protein L36a was normalized by α-actin of the same sample (ribosomal protein L36a/actin). The molsidomine effect on ribosomal protein L36a/actin is expressed relative to the age- and gender matched control, shown in graph by the dotted line (lower panel). The reduction in 2 week molsidomine males is borderline significant (*P* = 0.1). All 3 replicates are biological.](fgene-02-00052-g003){#F3}

![**Polysome profiles of kidneys**. Kidneys from control 2 day old (males *n* = 5, females *n* = 6), 2 week old (*n* = 8 in both genders), and adult (*n* = 4 in both genders) and molsidomine-treated 2 day old (males *n* = 4, females *n* = 6), 2 week old (*n* = 9 in both genders) and adult (*n* = 5 in both genders) FHH rats were profiled to measure the total number of assembled ribosome structures. The peaks of 40S, 60S, and 80S were normalized against the left-most peak and the results shown in the corresponding histograms. ^\#^*P* \< 0.01 vs. untreated of the same peak.](fgene-02-00052-g004){#F4}

Ribosomal evaluation
--------------------

Polysome profiling was performed on kidneys and the effects on the peaks representing the small ribosomal subunit (40S), large ribosomal subunit (60S), and monosome (80S) were determined (Figure [4](#F4){ref-type="fig"}). Two days after birth and in adults, molsidomine had no effect on polysome profiles, but 2 weeks after birth all peaks were significantly reduced by molsidomine in both males and females (*P* \< 0.01). This effect may be specific to the kidney, as no effect of molsidomine was observed in males at 2 weeks of age in liver polysome profiles (Figure [5](#F5){ref-type="fig"}). Northern blotting was performed on total RNA from 2 week FHH kidneys in order to determine rates of rRNA processing (Figure [A2](#FA2){ref-type="fig"} in Appendix). However, no differences were observed in processing using probes binding to either the external transcribed spacer (ETS) or the internal transcribed spacer 1 (ITS1).

![**Polysome profiles of livers**. Livers from 2-week-old FHH males were profiled to measure the total number of assembled ribosome structures. The peaks of 40S, 60S, and 80S were normalized against the left-most peak and the results shown in the corresponding histograms. Black and gray lines are from the control and molsidomine groups, respectively.](fgene-02-00052-g005){#F5}

Immunohistochemistry
--------------------

In order to determine if molsidomine resulted in a mitotic index change, we subjected kidneys from FHH rats to staining with a phospho-specific histone-3 (pH3) antibody (Figure [6](#F6){ref-type="fig"}). We saw no difference in the number of pH3-positive cells on molsidomine-treated FHH rat kidney slices compared to controls. As expected the number of pH3-positive cells decreased as the age of the rats increased. No pH3-positive cells were observed in adults (data not shown).

![**Phospho-histone H3 (pH3) immunohistochemistry**. Histology was performed on the kidneys from 2 day, 2 week and adult control and molsidomine FHH rats of both genders for pH3. An example of positive staining for pH3 in 2 day female molsidomine-treated FHH rat is shown in **(A)**. Several arrows indicate cells in mitosis staining positive for pH3. The number of positive cells at 2 days and 2 weeks is shown in **(B)**. Note that data in adults is not shown as all stained sections were completely negative for pH3.](fgene-02-00052-g006){#F6}

Discussion
==========

Nitric oxide donors are known to inhibit proliferation of mesangial and other glomerular cells *in vitro* (Rupprecht et al., [@B21]). Little is known about the effects of NO-donors on early growth and nephrogenesis. Recently we observed that administration of NO-donors during early development ameliorates the long-term phenotype in the FHH rat model of progressive hypertension-linked renal injury (Koeners et al., [@B15]). Assuming that the direct effects of the NO-donor in early development were related to an as of yet undefined aspect of renal development, the present study focused on a global analysis of ribosomal proteins as a key step in the post-transcriptional regulation of protein synthesis.

The prominent presence of ribosomal protein genes, especially in FHH males, on the lists of the most differentially expressed genes as a result of perinatal NO administration led us to examine how these changes in gene expression affected the protein levels of an individual ribosomal protein as well as the structures of mature, assembled ribosomes. Interestingly, when we measured the protein level of one of the most significantly differentially expressed gene in FHH males, ribosomal protein L36a, we found that only at 2 weeks of age did the change in gene expression correlate with a change in protein expression. This is in contrast to the ribosomal protein L36a protein levels at 2 days, which show no increase despite a substantial increase in ribosomal protein L36a gene expression at that age in males. This discrepancy may be due to the ribosome biogenesis machinery being saturated at 2 days of age and unable to incorporate higher levels of ribosomal proteins. The tight regulation of this biogenesis may likely be degrading excess ribosomal proteins at the protein level or blocking translation of ribosomal proteins at the mRNA level, although at present our data cannot distinguish between these two possibilities. No change in ribosomal protein L36a protein expression was observed in FHH females at 2 weeks of age, but this is not surprising given that no significant gene expression change of ribosomal protein L36a is seen in these animals. However, given the following data, it is likely that there is a reduction of one or more key ribosomal proteins at the protein level in FHH females at 2 weeks. Conceivably by the time the FHH rat has reached adulthood the kidney cells have adjusted the half-lives and/or degradation rates of certain ribosomal proteins in order to reach the normal number of mature ribosome structures.

The most significant finding of this study was that at 2 weeks after birth, i.e., at the end of nephrogenesis (Marquez et al., [@B17]), perinatal NO administration resulted in a global reduction of ribosome structures in both male and female FHH rats. All of the peaks representing major ribosome structures were found to be substantially decreased in molsidomine-treated FHH rats at 2 weeks of age. This global reduction in NO-treated females at 2 weeks was surprising because only two ribosomal protein genes, coding for ribosomal protein L16 and ribosomal protein L21, were significantly reduced. Ribosomal protein L16 gene expression was not reduced by molsidomine in FHH males at 2 weeks, but strikingly 6 out of the 45 genes that were significantly reduced coded for ribosomal protein L21. This suggests that ribosomal protein L21 may be a key ribosomal protein in the biogenesis of the 60S large subunit and may also play an unappreciated role in the biogenesis of the 40S subunit. Additionally, ribosomal protein L21 appears to be important in the development of craniofacial organs (Xie et al., [@B29]) and a missense mutation in L21 leads to hereditary hypotrichosis simplex in humans (Zhou et al., [@B30]). Our findings suggest that ribosomal protein L21 may have an as yet unrecognized role in the development of blood pressure control mechanisms of the kidney.

To our knowledge, this is the one of the most striking examples of a drug-induced decrease in ribosome biogenesis in an animal model to date that is not accompanied by deleterious effects. For example, rapamycin, a powerful inhibitor of the mTOR pathway that directly regulates ribosome biogenesis, when injected into rats had only a slight effect on polysome profiles of liver tissue (Reiter et al., [@B20]). However, doses of rapamycin as low as 1 ng/mL have been shown to negatively affect cell function and contribute to cell death, for instance in rodent islet cells (Bell et al., [@B2]; Tanemura et al., [@B25]). Moreover, many vertebrate and invertebrate models of deficiency of a single ribosomal protein due to gene deletion, knockdown, or missense mutations often show severe phenotypes (Caldarola et al., [@B6]), and models of biallelic loss of every ribosomal protein gene (with the one exception of ribosomal protein L22; Anderson et al., [@B1]) results in lethality. In contrast, our data suggest that a decrease of ribosome biogenesis during a critical period of nephrogenesis results in permanent physiologic changes to the kidney, which in turn ameliorate the hypertension phenotype late in life. Interestingly, the effects of exogenous NO on ribosomal biogenesis did not affect the liver, underlining the crucial role of NO in the developing cardiovascular system (Bustamante et al., [@B4]). An obvious change linked to a decrease in ribosome biogenesis would be a reduction in proliferation. However, immunohistochemistry did not reveal a change in proliferation. Note that although SIN-1, the active metabolite of molsidomine, can generate peroxynitrite *in vitro*, it appears to function solely as a NO-donor at *in vivo* oxygen concentrations (Singh et al., [@B23]). Indeed, recently we supplemented molsidomine to rescue cardiac function in rats with cardiorenal failure and found no increase in 3-nitrotyrosine in heart, kidney, or liver (Bongartz et al., [@B3]).

The mechanism of action of NO administered perinatally to FHH rats on ribosomal protein gene expression and the subsequent reduction of ribosome structures remains unclear. Indeed, direct measurement of whole kidney NO content at 2 weeks failed to show any effect of maternal NO-donor treatment, suggesting that the decrease in ribosome biogenesis at 2 weeks is programmed by an earlier event. Possibly maternal molsidomine intake results in increased placental transfer of NO adducts and increased fetal renal NO content. Alternatively, indirect effects on the placental circulation could play a role. Indeed, although previous studies (Cai et al., [@B5]) suggest a link between NO, rRNA synthesis and proliferation, we were unable to establish any differences in pre-rRNA levels in our model that would support direct effects of exogenous NO on rRNA production (Figure [A2](#FA2){ref-type="fig"} in Appendix). This suggests that the effect of NO at 2 weeks more likely lies within epigenetically programmed transcriptional changes of ribosomal protein genes, as demonstrated by the microarray results. Note that in a previous study we did find an increase in offspring kidney NO content when spontaneously hypertensive rat (SHR) dams were treated with citrulline (Koeners et al., [@B16]). Subsequently siblings of these SHR had a lower blood pressure than control SHR. The results of the present study suggest that mechanisms underlying the antihypertensive effects of perinatal administration of the NO-donor molsidomine in rats with genetic hypertension could be quite different.

It has been previously established that perinatal NO administration alleviates the hypertension phenotype in FHH rats (Koeners et al., [@B15]). The present study suggests a potential mechanism underlying this phenotype alleviation. At this stage we have no direct proof that the remarkable ribosomal changes we observe provide the causal mechanism for the beneficial effects of maternal NO on the blood pressure and renal function of the offspring. However, our data demonstrate a novel possibility that long-term amelioration of hypertension by NO in gestation may induce epigenetic changes that affect the postnatal transcription of ribosomal protein genes and a reduction of ribosome structures during a critical period of nephrogenesis.
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Methodology microarray
======================

After the hybridization of the samples to Illumina BeadChips RatRef-12 the raw data set containing all probes of each BeadArray was received. Each sample consisted of approximately 1 million beads, interrogating about 23K unique probes encoding genes (*n* = 22523), controls, housekeeping genes, and negative controls (*n* = 825). Each gene is probed with at least 30 beads. Before averaging the intensities of beads per probe, the outliers were removed, using the same approach to removing outliers as in BeadStudio. The removal of outliers was based on median ± 3× median absolute deviation (MAD) and all beads with intensities outside the area of median ± 3× MAD were removed. Outliers were frequent for each probe. In our hands close to 90% of the probes had outliers. Note that the outliers in "empty" beads, the negative controls (NC), were not removed, as they were considered to be background noise of the beads themselves. After removal of outliers (average 3 beads) the number of beads per probe averaged 39 beads.

After the test, the intensities of beads per probe are averaged for further data processing. Before the normalization procedure, the significance of a call from a gene was detected by applying a detection score that is dependent on the distribution of the intensities and the average intensity of the gene and NC (regardless of the number of NC). In this framework we performed the appropriate Student's *t*-test between the beads of a gene and the average intensity of all NC on the same array including testing (in)equality between two population variances in order to enhance reliability of the *t*-test. All probes with a significant call above the negative background were considered biologically active in the respective sample.

The software (T4Illumina) was written to process the raw data by averaging the intensities and determining the call of a gene, including determining the (un)equality of variance and many more. This software is available at request.

The significance of the presence of a gene in a group of samples (Figure [A1](#FA1){ref-type="fig"}) is outside the scope of the present study and will not be handled in this document. Note that all genes presented in the present study are significantly biologically active.

The averaged intensities, after removal of outliers, of the probes from all BeadArrays are Log~2~-transformed and quantile normalized. Next the arrays were grouped accordingly and the average intensity per group was calculated. Finally the significance of the differences in intensities between the groups was calculated using Cyber *t*-test. Cyber-T is a statistics program designed specifically for microarray data (<http://cybert.ics.uci.edu/>). The normalization, averaging, and statistics procedures can all be performed by the software *Flex- Array* ([http://gqinnovationcenter.com/services/bioinformatics/ flexarray/index.aspx?l=e](http://gqinnovationcenter.com/services/bioinformatics/ flexarray/index.aspx?l=e)).

Northern blot
=============

Total RNA was isolated from kidneys using Trizol using the procedure as recommended by the supplier (Invitrogen). Five microgram of RNA was run on a formaldehyde 1% agarose gel in MOPS buffer and DEPC-treated water for 4 h at 50 V. The gel was soaked in 50 mM NaOH for 15 min followed by 5 min in DEPC-treated water followed by 30 min in 10× SSC buffer. The RNA was transferred to a positively charged nylon membrane (GE Healthcare) overnight by capillary action and bound to the membrane by UV-crosslinking at 120 mJ. The blots were hybridized with DNA probes overnight in ExpressHyb Hybridization Buffer (Clontech) at 65°C. ETS and ITS1 DNA probes were made using the following primers: ETS FW: 5′-GTCTCGGTACGGGTGTGTC-3′ and REV 5′-TTTTTCCCCTTCCTCCTTTC-3′; ITS1 FW 5′-GGCCTGTGTGAGTGTTCCTC-3′ and REV 5′-TCAAGGGAAGA GCGAGAAAA-3′. Probes were labeled with ^32^P-αCTP (Perkin-Elmer) using a random primer DNA labeling system (Invitrogen). Following hybridization, blots were washed twice for 30 min with 0.1% SDS/0.2× SSC at 65°C. Blots were exposed on storage phosphorimaging screens (Molecular Dynamics) overnight and scanned using a Typhoon Scanner (GE Healthcare).

###### 

**Collection of the top 20 strongest up- and down-regulated genes at all ages in each gender**.

  Entrez gene ID                                                           Symbol        Definition                                                                             Gene expression                
  ------------------------------------------------------------------------ ------------- -------------------------------------------------------------------------------------- ----------------- ------------ ------------
  **A: TOP 40 OF MALE FHH OF 2 DAYS OLD (20 INDUCED AND 20 REDUCED)**                                                                                                                                          
  366411                                                                   RGD1560729    Ribosomal protein S24                                                                  **0.820**         −0.217       −0.354
  500817                                                                   RGD1563124    40S ribosomal protein S20                                                              **0.723**         **−0.317**   −0.409
  287029                                                                   RGD1562055    Ribosomal protein L31                                                                  **0.709**         **−0.399**   **−0.642**
  501876                                                                   RGD1563431    Large subunit ribosomal protein L36a                                                   **0.680**         **−0.424**   −0.383
  499560                                                                   LOC499560     LRRG00135                                                                              **0.657**         0.049        0.185
  289384                                                                   RGD1560186    Ribosomal protein L37                                                                  **0.632**         −0.192       **−0.844**
  500451                                                                   RGD1562259    40S ribosomal protein S20                                                              **0.534**         −0.114       **−0.452**
  362896                                                                   Stat6         Signal transducer and activator of transcription 6 (predicted), transcript variant 1   **0.526**         −0.221       −0.058
  501562                                                                   LOC501562     ORF2 consensus sequence encoding endonuclease and reverse transcriptase minus RNaseH   **0.514**         0.009        0.181
  171069                                                                   Usmg5         Upregulated during skeletal muscle growth 5                                            **0.508**         −0.372       **−0.651**
  367923                                                                   LOC367923     60S ribosomal protein L23a                                                             **0.503**         **−0.394**   −0.403
  362894                                                                   RGD1310066    mKIAA1002 protein                                                                      **0.493**         0.214        0.146
  314434                                                                   RGD1559566    60S ribosomal protein L9                                                               **0.488**         **−0.436**   −0.369
  291075                                                                   Peci          Peroxisomal delta3, delta2-enoyl-coenzyme A isomerase                                  **0.487**         −0.242       0.313
  680294                                                                   LOC680294     Ribosomal protein L19                                                                  **0.485**         **−0.312**   −0.510
  315338                                                                   Hoxc10        Homeo box C10                                                                          **0.480**         −0.137       −0.223
  500438                                                                   LOC500438     ORF2 consensus sequence encoding endonuclease and reverse transcriptase minus RNaseH   **0.478**         −0.083       0.026
  500923                                                                   RGD1565798    Tumor protein, translationally controlled 1                                            **0.478**         0.030        −0.106
  301434                                                                   Clk1          CDC-like kinase 1                                                                      **0.474**         0.081        0.282
  502887                                                                   RGD1563551    Ribosomal protein L31                                                                  **0.470**         −0.397       **−0.523**
  287422                                                                   Per1          Period homolog 1 (*Drosophila*)                                                        **−0.401**        **0.432**    **0.824**
  304063                                                                   Ets2 mapped   v-ets erythroblastosis virus E26 oncogene homolog 2 (avian)                            **−0.415**        0.104        −0.062
  25458                                                                    Gss           Glutathione synthetase                                                                 **−0.415**        0.134        0.320
  116546                                                                   Ralb          v-ral simian leukemia viral oncogene homolog B (ras related)                           **−0.417**        −0.007       0.090
  25122                                                                    Scnn1a        Sodium channel, non-voltage-gated, type I, alpha                                       **−0.417**        0.218        0.337
  64017                                                                    Enpep         Glutamyl aminopeptidase                                                                **−0.422**        0.102        0.787
  29144                                                                    Canx          Calnexin                                                                               **−0.431**        0.298        **0.689**
  24244                                                                    Calm3         Calmodulin 3                                                                           **−0.443**        0.037        0.067
  500300                                                                   LOC500300     Hypothetical protein MGC6835                                                           **−0.446**        0.090        **1.036**
  290551                                                                   Chdh          Choline dehydrogenase                                                                  **−0.456**        0.256        −0.028
  291081                                                                   RGD1309427    Tubulin, beta-like                                                                     **−0.462**        0.018        −0.344
  29517                                                                    Sgk           Serum/glucocorticoid regulated kinase                                                  **−0.466**        **0.661**    **0.862**
  294313                                                                   Mtch1         Mitochondrial carrier homolog 1 (*C. elegans*)                                         **−0.503**        −0.072       −0.138
  498290                                                                   RGD1561353    OTTHUMP00000044730                                                                     **−0.506**        0.040        0.267
  25365                                                                    Actg2         Actin, gamma 2, smooth muscle, enteric                                                 **−0.560**        0.018        0.079
  117273                                                                   Rhoa          ras homolog gene family, member A                                                      **−0.572**        −0.047       −0.171
  501211                                                                   LOC501211     LOC501211                                                                              **−0.608**        0.074        **−0.596**
  287571                                                                   Taf15         TAF15 RNA polymerase II, TATA box binding protein (TBP)-associated factor              **−0.712**        0.255        0.049
  25279                                                                    Cyp24a1       Cytochrome P450, subfamily 24                                                          **−0.849**        0.342        **−0.634**
  25633                                                                    Dnase1        Deoxyribonuclease I                                                                    **−0.861**        0.298        0.233
  **B: TOP 40 OF MALE FHH OF 2 WEEKS OLD (20 INDUCED AND 20 REDUCED)**                                                                                                                                         
  498789                                                                   RGD1564865    20-alpha-hydroxysteroid dehydrogenase                                                  0.056             **0.685**    −0.110
  29517                                                                    Sgk           Serum/glucocorticoid regulated kinase                                                  **−0.466**        **0.661**    **0.862**
  81676                                                                    Hnmt          Histamine *N*-methyltransferase                                                        0.028             **0.625**    **1.057**
  25526                                                                    Ptgds         Prostaglandin D2 synthase (brain)                                                      −0.089            **0.586**    **−0.559**
  362188                                                                   RGD1311652    MGC52019 protein                                                                       0.149             **0.584**    0.291
  83810                                                                    Trpv1         Transient receptor potential cation channel, subfamily  V, member 1                    0.022             **0.583**    −0.373
  246234                                                                   Slc34a3       Solute carrier family 34 (sodium phosphate), member 3                                  −0.149            **0.559**    −0.108
  171072                                                                   Sult1c2       Sulfotransferase family, cytosolic, 1C, member 2                                       0.326             **0.513**    **0.662**
  57300                                                                    Aadac         Arylacetamide deacetylase (esterase)                                                   −0.051            **0.508**    0.040
  25256                                                                    Fmo1          Flavin containing monooxygenase 1                                                      0.092             **0.506**    0.044
  363227                                                                   Obfc2a        Oligonucleotide/oligosaccharide-binding fold containing 2A                             0.145             **0.452**    −0.222
  79428                                                                    Luzp1         Leucine zipper protein 1                                                               −0.086            **0.443**    0.119
  287422                                                                   Per1          Period homolog 1                                                                       **−0.401**        **0.432**    **0.824**
  362216                                                                   Mrps26        Mitochondrial ribosomal protein S26                                                    −0.154            **0.427**    −0.330
  311826                                                                   Rexo4         REX4, RNA exonuclease 4 homolog (*S. cerevisiae*)                                      −0.083            **0.421**    0.125
  299944                                                                   RGD1304605    Hypothetical LOC299944                                                                 0.126             **0.406**    0.477
  303926                                                                   Igsf11        Immunoglobulin superfamily, member 11                                                  0.187             **0.403**    0.059
  293343                                                                   MGC94288      4632419K20Rik protein                                                                  −0.167            **0.401**    0.274
  24267                                                                    Comt          Catechol-*O*-methyltransferase                                                         −0.156            **0.397**    −0.180
  81641                                                                    Anpep         Alanyl (membrane) aminopeptidase                                                       0.007             **0.395**    0.083
  364108                                                                   RGD1562073    Ribosomal protein S17                                                                  **0.418**         **−0.517**   −0.490
  29258                                                                    Rps7          Ribosomal protein S7                                                                   −0.076            **−0.520**   −0.650
  60414                                                                    Rhd           Rh blood group, D antigen                                                              0.076             **−0.521**   0.066
  494500                                                                   Yc2           Glutathione *S*-transferase Yc2 subunit                                                0.390             **−0.550**   −0.078
  25748                                                                    Alas2         Aminolevulinic acid synthase 2, erythroid                                              0.021             **−0.569**   0.078
  24615                                                                    S100a4        S100 calcium-binding protein A4                                                        −0.090            **−0.573**   **−0.730**
  300024                                                                   LOC300024     Ly6-B antigen gene                                                                     −0.202            **−0.575**   −0.118
  500988                                                                   RGD1564560    RCK                                                                                    −0.111            **−0.623**   **0.905**
  500019                                                                   RGD1564980    60S ribosomal protein L29 (P23)                                                        −0.300            **−0.666**   −0.375
  25250                                                                    Cox8h         Cytochrome c oxidase subunit VIII-H (heart/muscle)                                     −0.037            **−0.689**   0.061
  54249                                                                    Cfd           Complement factor D (adipsin)                                                          0.001             **−0.702**   −0.297
  361619                                                                   MGC72973      Beta-glo                                                                               −0.232            **−0.747**   −0.638
  291541                                                                   Cidea         Cell death-inducing DNA fragmentation factor, alpha subunit-like effector A            −0.234            **−0.797**   0.132
  25357                                                                    Thrsp         Thyroid hormone responsive protein                                                     0.132             **−0.829**   0.021
  293522                                                                   Eraf          Erythroid associated factor                                                            −0.189            **−0.834**   −0.170
  54232                                                                    Ca3           Carbonic anhydrase 3                                                                   −0.249            **−0.867**   **−0.830**
  25475                                                                    Lgals5        Lectin, galactose binding, soluble 5                                                   −0.218            **−0.918**   −0.225
  81639                                                                    Alox15        Arachidonate 15-lipoxygenase                                                           −0.010            **−1.005**   0.035
  79451                                                                    Fabp4         Fatty acid binding protein 4, adipocyte                                                −0.189            **−1.067**   −0.061
  24860                                                                    Ucp1          Uncoupling protein 1 (mitochondrial, proton carrier)                                   −0.083            **−1.330**   0.041
  **C: TOP 40 OF ADULT MALE FHH (20 INDUCED AND 20 REDUCED)**                                                                                                                                                  
  117556                                                                   Sv2b          Synaptic vesicle glycoprotein 2b                                                       0.046             −0.471       **1.766**
  313089                                                                   Slc7a13       Solute carrier family 7 (cationic amino acid transporter, y + system) member 13        0.150             0.029        **1.419**
  498211                                                                   RGD1560523    *S*-adenosylmethionine synthetase gamma form (methionine adenosyltransferase)          −0.037            0.124        **1.251**
  50672                                                                    Ednrb         Endothelin receptor type B                                                             0.223             −0.396       **1.238**
  117560                                                                   Klf9          Kruppel-like factor 9                                                                  −0.138            −0.059       **1.220**
  501085                                                                   LOC501085     Sulfotransferase K1                                                                    −0.087            0.290        **1.181**
  497772                                                                   LOC497772     Hypothetical gene supported by NM_030827                                               0.183             0.259        **1.178**
  501610                                                                   LOC501610     Gag-Pol polyprotein                                                                    0.023             0.099        **1.123**
  316256                                                                   Tnfrsf21      Tumor necrosis factor receptor superfamily, member 21                                  −0.013            0.252        **1.112**
  367201                                                                   RGD1562392    Sulfotransferase K1 (rSULT1C2)                                                         0.007             0.136        **1.109**
  500621                                                                   LOC500621     Hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-coenzyme A thiolase                    −0.238            0.034        **1.104**
  313729                                                                   Errfi1        ERBB receptor feedback inhibitor 1                                                     0.002             0.084        **1.091**
  310395                                                                   LOC310395     Nocturnin (CCR4 protein homolog)                                                       −0.232            0.105        **1.074**
  361272                                                                   Dhtkd1        Dehydrogenase E1 and transketolase domain-containing 1                                 0.066             0.126        **1.060**
  81676                                                                    Hnmt          Histamine *N*-methyltransferase                                                        0.028             **0.625**    **1.057**
  364773                                                                   LOC364773     Liver regeneration-related protein LRRG07                                              **−0.370**        −0.192       **1.043**
  500300                                                                   LOC500300     Hypothetical protein MGC6835                                                           **−0.446**        0.090        **1.036**
  24861                                                                    Ugt1a1        UDP glycosyltransferase 1 family, polypeptide A1                                       0.246             0.091        **1.027**
  171361                                                                   Eef1a1        Eukaryotic translation elongation factor 1 alpha 1                                     0.101             **−0.260**   **1.007**
  301276                                                                   RGD1564912    Mut protein                                                                            −0.090            0.083        **0.999**
  500180                                                                   LOC500180     IG kappa-chain V--V region K2 precursor                                                0.002             0.024        **−0.796**
  502302                                                                   LOC502302     40S ribosomal protein S19                                                              0.002             −0.034       **−0.796**
  29191                                                                    Tac2          Tachykinin 2                                                                           −0.008            0.014        **−0.805**
  362506                                                                   Ccl19         Chemokine (C--C motif) ligand 19                                                       0.043             −0.170       **−0.812**
  363074                                                                   RGD1309779    ENSANGP00000021391                                                                     −0.061            −0.042       **−0.815**
  499300                                                                   Ptprcap       Protein tyrosine phosphatase, receptor type, C polypeptide-associated protein          0.009             −0.007       **−0.817**
  361537                                                                   Tyrobp        Tyro protein tyrosine kinase binding protein                                           0.030             −0.129       **−0.824**
  54232                                                                    Ca3           Carbonic anhydrase 3                                                                   −0.249            **−0.867**   **−0.830**
  299269                                                                   isg12(b)      Putative ISG12(b) protein                                                              −0.072            −0.169       **−0.833**
  292654                                                                   RGD1564549    Hypothetical protein FLJ20512                                                          −0.173            0.064        **−0.840**
  289384                                                                   RGD1560186    Ribosomal protein L37                                                                  **0.632**         −0.192       **−0.844**
  360918                                                                   Pf4           Platelet factor 4                                                                      0.106             −0.299       **−0.845**
  498744                                                                   RGD1561310    Ribosomal protein L37                                                                  0.151             **−0.454**   **−0.851**
  367077                                                                   RGD1562835    40S ribosomal protein S26                                                              0.170             −0.348       **−0.852**
  24440                                                                    Hbb           Hemoglobin beta chain complex                                                          −0.237            −0.127       **−0.857**
  25632                                                                    Hba-a2        Hemoglobin alpha, adult chain 2                                                        −0.105            −0.016       **−0.860**
  299848                                                                   RGD1565117    40S ribosomal protein S26                                                              0.029             −0.217       **−0.882**
  499131                                                                   LOC499131     NADH:ubiquinone oxidoreductase B15 subunit                                             −0.075            −0.156       **−0.909**
  140608                                                                   Atp5i         ATP synthase, H+ transporting, mitochondrial F0 complex, subunit e                     −0.139            −0.008       **−0.971**
  692000                                                                   LOC692000     Dolichol-phosphate mannosyltransferase subunit 3                                       −0.190            0.095        **−1.014**
  **D: TOP 40 OF FEMALE FHH OF 2 DAYS OLD (20 INDUCED AND 20 REDUCED)**                                                                                                                                        
  499638                                                                   LOC499638     LRRGT00057                                                                             **1.238**         0.031        0.087
  361117                                                                   LOC361117     LRRGT00149                                                                             **1.206**         −0.117       −0.136
  500285                                                                   LOC500285     LRRGT00176                                                                             **1.198**         −0.039       0.029
  498105                                                                   LOC498105     LRRGT00176                                                                             **1.186**         0.049        −0.044
  498076                                                                   LOC498076     RIKEN cDNA 2410116I05                                                                  **1.124**         0.041        0.103
  500586                                                                   LOC500586     LRRGT00057                                                                             **1.110**         −0.046       −0.062
  498245                                                                   LOC498245     LRRGT00176                                                                             **1.105**         0.037        −0.039
  313278                                                                   RGD1561090    Protein tyrosine phosphatase, receptor type, D                                         **0.978**         −0.065       0.104
  362803                                                                   LOC362803     Putative RNA binding protein 1                                                         **0.888**         0.045        −0.109
  500380                                                                   LOC500380     LRRGT00008                                                                             **0.885**         0.117        −0.258
  498623                                                                   LOC498623     LRRGT00176                                                                             **0.844**         0.044        −0.102
  501156                                                                   LOC501156     LRRGT00176                                                                             **0.793**         0.074        −0.293
  500988                                                                   RGD1564560    RCK                                                                                    **0.791**         −0.432       −0.473
  498979                                                                   LOC498979     LRRGT00194                                                                             **0.763**         0.035        −0.147
  25365                                                                    Actg2         Actin, gamma 2, smooth muscle, enteric                                                 **0.752**         **−0.435**   −0.126
  309902                                                                   Cxxc6         CXXC finger 6                                                                          **0.738**         0.107        −0.008
  500343                                                                   LOC500343     LRRGT00176                                                                             **0.734**         0.110        −0.138
  315604                                                                   Ddx6          DEAD (Asp-Glu-Ala-Asp) box polypeptide 6                                               **0.597**         −0.305       −0.006
  498217                                                                   LOC498217     LRRG00135                                                                              **0.595**         0.063        −0.015
  308831                                                                   Odz4          Odd Oz/ten-m homolog 4 (*Drosophila*)                                                  **0.595**         −0.052       0.140
  24832                                                                    Thy1          Thymus cell antigen 1, theta                                                           **−0.336**        −0.161       0.319
  366942                                                                   RGD1565809    Ribosomal protein L15                                                                  **−0.345**        −0.070       0.010
  362850                                                                   Angptl4       Angiopoietin-like 4                                                                    **−0.352**        −0.311       −0.221
  25475                                                                    Lgals5        Lectin, galactose binding, soluble 5                                                   **−0.356**        −0.162       0.207
  64473                                                                    Bpnt1         Bisphosphate 3′-nucleotidase 1                                                         **−0.359**        −0.134       0.009
  338475                                                                   Nrep          Neuronal regeneration-related protein                                                  **−0.370**        −0.154       0.300
  294282                                                                   Rps18         Ribosomal protein S18                                                                  **−0.377**        −0.016       0.021
  140582                                                                   Ddit4l        DNA-damage-inducible transcript 4-like                                                 **−0.389**        −0.186       −0.055
  360941                                                                   LOC360941     ORF7                                                                                   **−0.420**        0.033        0.076
  117273                                                                   Rhoa          ras homolog gene family, member A                                                      **−0.423**        −0.239       −0.189
  29222                                                                    Ptma          Prothymosin alpha                                                                      **−0.426**        −0.167       0.207
  315745                                                                   Fem1b         Feminization 1 homolog b (*C. elegans*)                                                **−0.448**        −0.074       0.167
  124440                                                                   Rpl 41        Ribosomal protein L41                                                                  **−0.455**        0.034        0.067
  314397                                                                   Rin3          Ras and Rab interactor 3                                                               **−0.497**        −0.156       −0.188
  89813                                                                    Pdk4          Pyruvate dehydrogenase kinase, isoenzyme 4                                             **−0.498**        **−0.357**   **0.533**
  287571                                                                   Taf15         TAF15 RNA polymerase II, TATA box binding protein (TBP)-associated factor              **−0.503**        −0.197       0.113
  308568                                                                   RGD1309326    RIKEN cDNA 2410002F23                                                                  **−0.539**        −0.154       −0.089
  246771                                                                   Slc25a25      Solute carrier family 25 (mitochondrial carrier, phosphate carrier) member 25          **−0.575**        **−0.393**   −0.111
  25633                                                                    Dnase1        Deoxyribonuclease I                                                                    **−0.588**        **−0.250**   −0.274
  360739                                                                   Ranbp1        RAN binding protein 1                                                                  **−0.597**        −0.306       0.453
  **E: TOP 40 OF FEMALE FHH OF 2 WEEKS OLD (20 INDUCED AND 20 REDUCED)**                                                                                                                                       
  24567                                                                    Mt1a          Metallothionein 1a                                                                     −0.154            **0.424**    −0.075
  64522                                                                    Slc5a2        Solute carrier family 5 (sodium/glucose cotransporter) member 2                        −0.110            **0.419**    −0.362
  362334                                                                   Tmem140       Transmembrane protein 140                                                              0.205             **0.359**    −0.333
  313430                                                                   Fam151a       Family with sequence similarity 151, member A                                          −0.061            **0.325**    −0.358
  360895                                                                   Rrp15         Ribosomal RNA processing 15 homolog (*S. cerevisiae*)                                  0.067             **0.324**    −0.001
  362334                                                                   Tmem140       Transmembrane protein 140                                                              0.207             **0.284**    0.051
  289419                                                                   Nuak2         NUAK family, SNF1-like kinase, 2                                                       0.037             **0.278**    −0.257
  307098                                                                   Net1          Neuroepithelial cell transforming gene 1                                               −0.058            **0.278**    −0.049
  24484                                                                    Igfbp3        Insulin-like growth factor binding protein 3                                           **0.267**         **0.270**    −0.206
  303002                                                                   RGD1308952    mKIAA0665 protein                                                                      0.052             **0.263**    −0.163
  85385                                                                    Shc1          src homology 2 domain-containing transforming protein C1                               0.094             **0.261**    0.123
  300659                                                                   Rnf26         Ring finger protein 26                                                                 −0.166            **0.253**    0.085
  404871                                                                   Olr557        Olfactory receptor 557 (predicted)                                                     0.023             **0.251**    −0.213
  360228                                                                   LOC360228     WDNM1 homolog                                                                          0.257             **0.248**    −0.243
  116565                                                                   Lrpap1        Low density lipoprotein receptor-related protein associated protein 1                  0.036             **0.248**    −0.180
  25619                                                                    Plau          Plasminogen activator, urokinase                                                       **0.225**         **0.242**    −0.071
  361367                                                                   Amfr          Autocrine motility factor receptor                                                     0.043             **0.239**    −0.135
  171179                                                                   Keg1          Kidney expressed gene 1                                                                0.014             **0.238**    −0.115
  310810                                                                   Sdfr2         Stromal cell derived factor receptor 2                                                 **0.211**         **0.232**    0.027
  299027                                                                   Eif2s3x       Eukaryotic translation initiation factor 2, subunit 3, structural gene X-linked        −0.021            **0.228**    0.096
  24856                                                                    Ttr           Transthyretin                                                                          0.115             **−0.331**   0.062
  309809                                                                   RGD1310495    KIAA1919 protein                                                                       −0.028            **−0.336**   −0.184
  311676                                                                   Tmepai        Transmembrane, prostate androgen induced RNA                                           0.033             **−0.340**   0.199
  89813                                                                    Pdk4          Pyruvate dehydrogenase kinase, isoenzyme 4                                             **−0.498**        **−0.357**   **0.533**
  246781                                                                   Ptpn7         Protein tyrosine phosphatase, non-receptor type 7                                      −0.008            **−0.364**   0.101
  501194                                                                   LOC501194     Hypothetical protein D330021B20                                                        0.249             **−0.365**   −0.110
  291555                                                                   Atp8b1        ATPase, class I, type 8B, member 1                                                     0.091             **−0.392**   −0.097
  246771                                                                   Slc25a25      Solute carrier family 25 (mitochondrial carrier, phosphate carrier) member 25          **−0.575**        **−0.393**   −0.111
  303132                                                                   Aff4          AF4/FMR2 family, member 4                                                              −0.014            **−0.399**   0.057
  295660                                                                   RGD1564400    Eukaryotic translation initiation factor 5                                             −0.057            **−0.407**   −0.231
  361296                                                                   Rnf125        Ring finger protein 125                                                                0.270             **−0.407**   −0.134
  64353                                                                    Pdlim5        PDZ and LIM domain 5                                                                   −0.063            **−0.411**   −0.297
  25365                                                                    Actg2         Actin, gamma 2, smooth muscle, enteric                                                 **0.752**         **−0.435**   −0.126
  498859                                                                   LOC498859     LOC498859                                                                              −0.002            **−0.449**   −0.111
  315190                                                                   Upk3a         Uroplakin 3A                                                                           **0.317**         **−0.459**   −0.297
  501530                                                                   LOC501530     LOC501530                                                                              0.442             **−0.487**   **0.438**
  290704                                                                   LOC290704     Palladin                                                                               0.371             **−0.516**   −0.324
  94197                                                                    Rab14         RAB14, member RAS oncogene family                                                      0.122             **−0.565**   −0.194
  25373                                                                    Ahsg          Alpha-2-HS-glycoprotein                                                                0.031             **−0.711**   0.092
  498989                                                                   LOC498989     Ab2-143                                                                                0.646             **−0.728**   −0.269
  **F: TOP 40 OF ADULT FEMALE FHH (20 INDUCED AND 20 REDUCED)**                                                                                                                                                
  361734                                                                   Ms4a4a        Membrane-spanning 4-domains, subfamily A, member 4                                     −0.013            0.006        **1.155**
  117518                                                                   Ccl17         Chemokine (C--C motif) ligand 17                                                       −0.091            −0.034       **1.052**
  406161                                                                   C4-2          Complement component 4, gene 2                                                         0.048             0.197        **0.885**
  304349                                                                   RGD1559588    Cell surface receptor FDFACT                                                           0.010             −0.105       **0.877**
  500172                                                                   LOC500172     Immunoglobulin kappa-chain                                                             0.067             −0.083       **0.871**
  29517                                                                    Sgk           Serum/glucocorticoid regulated kinase                                                  0.142             0.027        **0.861**
  498982                                                                   RGD1560020    Myb proto-oncogene protein                                                             0.143             0.078        **0.801**
  298906                                                                   Pqlc3         PQ loop repeat containing 3                                                            −0.044            −0.012       **0.795**
  116676                                                                   Aldh1a2       Aldehyde dehydrogenase family 1, subfamily A2                                          0.216             0.134        **0.790**
  64195                                                                    Mgl1          Macrophage galactose *N*-acetyl-galactosamine specific lectin 1                        −0.077            −0.030       **0.769**
  29168                                                                    Ubd           Ubiquitin D                                                                            −0.115            0.087        **0.754**
  313438                                                                   Dock11        Dedicator of cytokinesis 11                                                            0.024             −0.113       **0.727**
  681872                                                                   LOC681872     Interleukin 19                                                                         0.038             −0.033       **0.726**
  246143                                                                   Nradd         Neurotrophin receptor associated death domain                                          −0.032            0.041        **0.726**
  84032                                                                    Col3a1        Collagen, type III, alpha 1                                                            0.057             −0.029       **0.716**
  24366                                                                    Fgb           Fibrinogen, B beta polypeptide                                                         0.022             0.195        **0.709**
  502902                                                                   RGD1565140    Clecsf12 protein                                                                       −0.066            −0.009       **0.692**
  501405                                                                   LOC501405     GTPase activating protein testicular GAP1                                              −0.015            −0.013       **0.691**
  24251                                                                    Cd53          CD53 antigen                                                                           0.035             −0.049       **0.681**
  298975                                                                   Scin          Scinderin                                                                              0.095             0.095        **0.679**
  309527                                                                   Ch25h         Cholesterol 25−hydroxylase                                                             0.055             −0.014       **−0.713**
  286926                                                                   Tfpi2         Tissue factor pathway inhibitor 2                                                      0.019             −0.005       **−0.725**
  293538                                                                   RGD1565366    Hmx2 protein                                                                           **0.256**         −0.049       **−0.737**
  24517                                                                    Junb          Jun-B oncogene                                                                         0.116             −0.039       **−0.745**
  24451                                                                    Hmox1         Heme oxygenase (decycling) 1                                                           0.155             0.248        **−0.771**
  292868                                                                   Klks3         Kallikrein, submaxillary gland S3                                                      −0.113            −0.039       **−0.771**
  363483                                                                   Dmrtc1c       DMRT-like family C1c                                                                   0.096             0.076        **−0.808**
  24498                                                                    Il6           Interleukin 6                                                                          0.055             −0.099       **−0.826**
  78965                                                                    Csf1          Colony stimulating factor 1 (macrophage)                                               0.131             0.064        **−0.837**
  24296                                                                    Cyp1a1        Cytochrome P450, family 1, subfamily a, polypeptide 1                                  0.102             −0.062       **−0.857**
  24508                                                                    Irf1          Interferon regulatory factor 1                                                         **−0.214**        0.033        **−0.894**
  25542                                                                    Ccl3          Chemokine (C--C motif) ligand 3                                                        0.102             0.064        **−0.923**
  25464                                                                    Icam1         Intercellular adhesion molecule 1                                                      −0.177            −0.058       **−0.965**
  25361                                                                    Vcam1         Vascular cell adhesion molecule 1                                                      0.133             −0.038       **−1.099**
  362993                                                                   Rnd1          Rho family GTPase 1                                                                    0.054             −0.031       **−1.161**
  24770                                                                    Ccl2          Chemokine (C--C motif) ligand 2                                                        −0.007            −0.083       **−1.232**
  116637                                                                   Ccl4          Chemokine (C--C motif) ligand 4                                                        0.067             0.029        **−1.322**
  114105                                                                   Cxcl2         Chemokine (C--X--C motif) ligand 2                                                     −0.091            0.069        **−1.504**
  25651                                                                    Selp          Selectin, platelet                                                                     −0.078            −0.032       **−1.531**
  81503                                                                    Cxcl1         Chemokine (C--X--C motif) ligand 1                                                     −0.075            −0.010       **−2.156**

*The difference in gene expression between molsidomine-treated and control FHH was noted as Log~2~(FM/FC), where FM and FC are the normalized intensities. Red and blue numbers indicate gene expression differentially induced and reduced by molsidomine, respectively*.

###### 

**Ribosomal protein genes in kidneys of FHH males differentially expressed by molsidomine (FM, 2 days and 2 weeks) or after perinatal molsidomine (FM, adult) vs. controls (FC)**.

  Entrez gene ID    Ribosome   Chromosome   Gene expression                
  ----------------- ---------- ------------ ----------------- ------------ ------------
  **A: 2 DAYS**                                                            
  366411            S24        5            **0.820**         −0.217       −0.354
  500817            S20        7            **0.723**         **−0.317**   −0.409
  287029            L31        10           **0.709**         **−0.399**   **−0.642**
  501876            L36a       13           **0.680**         **−0.424**   −0.383
  289384            L37        13           **0.632**         −0.192       **−0.844**
  500451            S20        5            **0.534**         −0.114       **−0.452**
  367923            L23a       3            **0.503**         **−0.394**   −0.403
  314434            L9         X            **0.488**         **−0.436**   −0.369
  680294            L19        --           **0.485**         **−0.312**   −0.510
  502887            L31        4            **0.470**         −0.397       **−0.523**
  500322            S7         4            **0.462**         −0.192       −0.411
  500510            L21        5            **0.437**         −0.044       −0.432
  498078            L7a        11           **0.427**         −0.331       −0.354
  364108            S17        14           **0.418**         **−0.517**   −0.490
  294700            L21        2            **0.409**         **−0.434**   −0.293
  287417            L26        10           **0.399**         **−0.228**   −0.253
  295439            L21        2            **0.353**         **−0.334**   −0.175
  314733            S19        7            **0.329**         −0.330       **−0.638**
  289715            L37        14           **0.314**         **−0.454**   **−0.554**
  364059            L34        13           **0.299**         **−0.352**   **−0.662**
  365800            L36a       4            **0.280**         −0.014       −0.131
  498828            L10        18           **0.276**         −0.241       −0.306
  364825            L36        18           **−0.199**        0.117        0.126
  **B: 2 WEEKS**                                                           
  362216            S26        3            −0.154            **0.427**    −0.330
  308719            L27a       1            −0.068            **0.243**    0.044
  503211            L21        8            −0.051            **0.161**    0.111
  367030            SA         8            0.106             **0.155**    −0.061
  287417            L26        10           **0.399**         **−0.228**   −0.253
  298126            L31        5            0.018             **−0.261**   **−0.566**
  313283            S12        5            0.045             **−0.279**   **−0.548**
  287996            L21        11           −0.022            **−0.281**   0.002
  296870            L34        X            −0.008            **−0.295**   −0.283
  364828            L29        18           0.132             **−0.297**   −0.506
  500559            S20        5            0.132             **−0.302**   −0.188
  498360            S23        14           0.033             **−0.304**   −0.164
  680294            L19        --           **0.485**         **−0.312**   −0.510
  500817            S20        7            **0.723**         **−0.317**   −0.409
  367102            S9         8            −0.068            **−0.325**   **−0.458**
  299935            L31        7            0.001             **−0.328**   **−0.461**
  295439            L21        2            **0.353**         **−0.334**   −0.175
  364059            L34        13           **0.299**         **−0.352**   **−0.662**
  300731            L21        8            0.061             **−0.352**   −0.638
  499133            L27a       1            0.119             **−0.363**   **−0.477**
  687298            S19        10           0.059             **−0.365**   −0.541
  366656            L10a       6            0.188             **−0.370**   −0.260
  502854            L31        4            0.166             **−0.376**   **−0.624**
  297755            L7         5            0.252             **−0.386**   −0.308
  294781            L21        2            0.397             **−0.388**   **−0.627**
  65139             S12        1            0.225             **−0.393**   **−0.765**
  367923            L23a       3            **0.503**         **−0.394**   −0.403
  287029            L31        10           **0.709**         **−0.399**   **−0.642**
  501604            L7a        X            0.287             **−0.402**   −0.218
  81772             S9         1            0.252             **−0.406**   **−0.620**
  289401            L31        13           0.243             **−0.424**   **−0.735**
  501876            L36a       13           **0.680**         **−0.424**   −0.383
  299740            L31        7            −0.024            **−0.426**   −0.539
  294700            L21        2            **0.409**         **−0.434**   −0.293
  314434            L9         X            **0.488**         **−0.436**   −0.369
  300278            S9         X            0.414             **−0.436**   **−0.590**
  289715            L37        14           **0.314**         **−0.454**   **−0.554**
  498744            L37        17           0.151             **−0.454**   **−0.851**
  501058            S23        8            0.054             **−0.467**   −0.297
  363418            L17        12           0.068             **−0.469**   −0.316
  81770             L37        2            −0.136            **−0.472**   −0.618
  500817            S20        7            0.080             **−0.484**   −0.347
  363861            L29        12           0.212             **−0.490**   −0.467
  366887            L31        7            0.379             **−0.497**   −0.497
  686564            L23a       14           0.520             **−0.497**   −0.446
  364139            L21        14           0.150             **−0.497**   −0.758
  364108            S17        14           **0.418**         **−0.517**   −0.490
  29258             S7         5            −0.076            **−0.520**   −0.650
  500019            L29        4            −0.300            **−0.666**   −0.375
  **C: 36 WEEKS**                                                          
  360710            L7a        11           0.034             0.157        **0.218**
  365300            L7         1            −0.007            0.004        **−0.213**
  294282            S18        20           −0.094            −0.010       **−0.337**
  498837            S27a       18           0.196             −0.043       **−0.342**
  315521            L32        8            0.339             0.010        **−0.363**
  367250            L7a        9            0.021             0.060        **−0.371**
  365560            L36a       20           0.030             −0.097       **−0.384**
  500451            S20        5            **0.534**         −0.114       **−0.452**
  367102            S9         8            −0.068            **−0.325**   **−0.458**
  299935            L31        7            0.001             **−0.328**   **−0.461**
  499133            L27a       1            0.119             **−0.363**   **−0.477**
  500559            S20        5            0.220             −0.339       **−0.490**
  309408            S12        1            −0.079            −0.134       **−0.495**
  498954            S16        19           0.099             −0.171       **−0.499**
  302497            L10a       X            0.334             −0.262       **−0.499**
  25347             L39        X            0.014             −0.145       **−0.512**
  302898            L1         10           0.034             0.076        **−0.515**
  302528            L37a       X            0.006             −0.041       **−0.520**
  502887            L31        4            **0.470**         −0.397       **−0.523**
  499752            L7a        3            0.115             −0.093       **−0.527**
  124323            S23        2            0.163             −0.260       **−0.529**
  293754            L16        1            −0.278            0.116        **−0.548**
  313283            S12        5            0.045             **−0.279**   **−0.548**
  289715            L37        14           **0.314**         **−0.454**   **−0.554**
  315642            L27a       8            −0.162            −0.126       **−0.560**
  298495            L35a       5            0.296             −0.332       **−0.565**
  298126            L31        5            0.018             **−0.261**   **−0.566**
  366689            L21        6            −0.128            −0.317       **−0.575**
  81768             L22        5            0.002             −0.148       **−0.580**
  300278            S9         X            0.414             **−0.436**   **−0.590**
  292539            L17        1            0.237             −0.246       **−0.592**
  498363            P2         14           0.481             −0.130       **−0.597**
  299041            P1         X            0.041             −0.157       **−0.601**
  57809             L35a       1            −0.112            −0.210       **−0.614**
  81772             S9         1            0.252             **−0.406**   **−0.620**
  502854            L31        4            0.166             **−0.376**   **−0.624**
  294781            L21        2            0.397             **−0.388**   **−0.627**
  314054            S10        6            −0.053            −0.170       **−0.631**
  314733            S19        7            **0.329**         −0.330       **−0.638**
  287029            L31        10           **0.709**         **−0.399**   **−0.642**
  498555            P2         15           0.002             −0.072       **−0.645**
  503110            S19        7            0.008             −0.047       **−0.651**
  64360             L23        1            −0.247            0.029        **−0.654**
  297459            S25        4            −0.247            0.160        **−0.659**
  314248            S17        6            0.000             −0.064       **−0.661**
  364059            L34        13           **0.299**         **−0.352**   **−0.662**
  171061            L17        1            0.219             −0.170       **−0.663**
  366485            --         5            −0.275            −0.376       **−0.665**
  500714            L6         6            0.023             −0.218       **−0.686**
  289401            L31        13           0.243             **−0.424**   **−0.735**
  27139             S26        7            0.205             −0.240       **−0.760**
  65139             S12        1            0.225             **−0.393**   **−0.765**
  498523            L23a       15           −0.134            −0.253       **−0.766**
  289932            S7         15           0.098             −0.295       **−0.785**
  502302            S19        1            0.002             −0.034       **−0.796**
  289384            L37        13           **0.632**         −0.192       **−0.844**
  498744            L37        17           0.151             **−0.454**   **−0.851**
  367077            S26        8            0.170             −0.348       **−0.852**
  299848            S26        7            0.029             −0.217       **−0.882**

*All genes that are significantly differentially expressed by molsidomine are arranged per age \[**(A)** is newborn males, i.e., 2 days, **(B)** is 2-week-old males, and **(C)** is adult males, i.e., 36 weeks\]. The difference in gene expression between molsidomine-treated and control FHH was noted as Log~2~(FM/FC), where FM and FC are the normalized intensities. Red and blue numbers indicate gene expression differentially induced and reduced by molsidomine, respectively. The symbols and the chromosomal locations are also shown. Ratios indicated in bold and red are increased differential expression and ratios indicated in bold and blue are decreased differential expression. Note that some genes in **(A)** may reappear in **(B,C)** and some genes in Table A2B may reappear in Table A2C*.

![**Total number of genes differentially expressed by molsidomine at each age per gender**. Hundreds of genes were significantly affected by molsidomine at each age in both genders. The distribution of the genes over all ages is shown in a Venn diagram. The up and down arrows indicate genes that are differentially induced or reduced by molsidomine vs. control, respectively. Below the diagram are the total numbers of genes that are differentially expressed by molsidomine vs. control.](fgene-02-00052-a001){#FA1}

![**Northern Blots**. Northern blotting was performed on kidneys from 2 week FHH in order to determine rates of pre-rRNA processing. ETS: external transcribed spacer. ITS1: internal transcribed spacer 1. Ethidium bromide (EtBr) is shown as loading control. Note the slight decrease of molsidomine-treated males is due to loading (seen by EtBr) and not due to processing defects of pre-rRNA.](fgene-02-00052-a002){#FA2}

Abbreviations
=============

FHH, fawn-hooded hypertensive rat; NO, nitric oxide.
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